Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milton C Weinstein

Showing results (31-40 of 211) with videos related to

Pageof 22
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 27, 2010
The combined analysis of uncertainty and patient heterogeneity in medical decision modelsBas Groot Koerkamp, Theo Stijnen, Milton C Weinstein, et al.
Health Economics|January 4, 2006
Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methodsBas Groot Koerkamp, M G Myriam Hunink, Theo Stijnen, et al.
Plos Medicine|November 16, 2006
Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim, Joshua A Salomon, Milton C Weinstein, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Sexually Transmitted Diseases|June 25, 2005
The cost effectiveness of gonorrhea screening in urban emergency departmentsJulia E Aledort, Edward W Hook, Milton C Weinstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2008
Cost-effectiveness of HIV testing and treatment in the United StatesRochelle P Walensky, Kenneth A Freedberg, Milton C Weinstein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Patient and community preferences for treatments and health states in multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
American Journal of Epidemiology|October 9, 2002
Empirically calibrated model of hepatitis C virus infection in the United StatesJoshua A Salomon, Milton C Weinstein, James K Hammitt, et al.
JAMA|July 15, 2015
Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular DiseaseAnkur Pandya, Stephen Sy, Sylvia Cho, et al.
BMC Pregnancy and Childbirth|September 25, 2009
Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant womenJennifer Prah Ruger, Karen M Emmons, Margaret H Kearney, et al.
Pageof 22

Showing results (31-40 of 211) with videos related to

Sort By:
Pageof 22
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 27, 2010
The combined analysis of uncertainty and patient heterogeneity in medical decision modelsBas Groot Koerkamp, Theo Stijnen, Milton C Weinstein, et al.
Health Economics|January 4, 2006
Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methodsBas Groot Koerkamp, M G Myriam Hunink, Theo Stijnen, et al.
Plos Medicine|November 16, 2006
Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim, Joshua A Salomon, Milton C Weinstein, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Sexually Transmitted Diseases|June 25, 2005
The cost effectiveness of gonorrhea screening in urban emergency departmentsJulia E Aledort, Edward W Hook, Milton C Weinstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2008
Cost-effectiveness of HIV testing and treatment in the United StatesRochelle P Walensky, Kenneth A Freedberg, Milton C Weinstein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Patient and community preferences for treatments and health states in multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
American Journal of Epidemiology|October 9, 2002
Empirically calibrated model of hepatitis C virus infection in the United StatesJoshua A Salomon, Milton C Weinstein, James K Hammitt, et al.
JAMA|July 15, 2015
Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular DiseaseAnkur Pandya, Stephen Sy, Sylvia Cho, et al.
BMC Pregnancy and Childbirth|September 25, 2009
Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant womenJennifer Prah Ruger, Karen M Emmons, Margaret H Kearney, et al.
Pageof 22